Barbican Dental Care has been acquired by Bupa Dental Services
The shareholders of Barbican Dental Care have sold the company to Bupa Dental Services (Bupa), the UK-based international healthcare group. Financial terms of this transaction have not been disclosed.
Barbican Dental Care is a specialist corporate dental business, offering affordable private dental care and corporate dental plans to companies based in the City, West End and Canary Wharf. The 24 surgeries operate from nine sites providing general, specialist and cosmetic dentistry.
Bupa provides international healthcare support and advisory services. This transaction meets Bupa’s strategy to acquire high quality private practices based in locations that are convenient for corporate and business centers.
Neil Sikka, who founded Barbican Dental Care in 1992, said: “I am very excited about the opportunity to grow the business within Bupa Dental Services and look forward to working with Bupa on the initial integration and subsequent expansion of their dental services.”
Oaklins Cavendish, based in the UK, advised the shareholders of Barbican Dental Care in this transaction. The team's specialist commented: “Barbican Dental Care’s unique business-to-business service proposition and high quality, well run private surgeries generated significant interest. Neil has successfully developed the business through his constant focus on the provision of high quality private dental services in state-of-the-art facilities.”
Talk to the deal team
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more